Literature DB >> 30459163

The ERSPC Study: Quality Takes Time and Perseverance.

Monique J Roobol1, Sigrid V Carlsson2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30459163      PMCID： PMC6339698          DOI： 10.1373/clinchem.2018.287110

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  4 in total

1.  European Randomized Study of Screening for Prostate Cancer: achievements and presentation.

Authors:  M J Roobol; F H Schröder
Journal:  BJU Int       Date:  2003-12       Impact factor: 5.588

2.  Re: Re-evaluating PSA Testing Rates in the PLCO Trial.

Authors:  Monique J Roobol
Journal:  Eur Urol       Date:  2016-08-02       Impact factor: 20.096

3.  International trends and patterns of prostate cancer incidence and mortality.

Authors:  A W Hsing; L Tsao; S S Devesa
Journal:  Int J Cancer       Date:  2000-01-01       Impact factor: 7.396

4.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

Authors:  W J Catalona; D S Smith; T L Ratliff; K M Dodds; D E Coplen; J J Yuan; J A Petros; G L Andriole
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245
  4 in total
  1 in total

Review 1.  Personalized strategies in population screening for prostate cancer.

Authors:  Sebastiaan Remmers; Monique J Roobol
Journal:  Int J Cancer       Date:  2020-06-03       Impact factor: 7.396
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.